Your browser doesn't support javascript.
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
1.
Iranian Red Crescent Medical Journal ; 24(12), 2022.
Article in English | CAB Abstracts | ID: covidwho-2262035

ABSTRACT

Background: Anxiety is common among university students and previous research has highlighted the association between the COVID-19 pandemic and higher anxiety scores in the public. Objectives: In this regard, this study aimed to evaluate the effect of the COVID-19 pandemic on the anxiety status of pharmacy students studying in Northern Cyprus and analyze the role of some parameters on the observed anxiety scores. Methods: Anxiety scores of 185 pharmacy students studying at two universities in Northern Cyprus were evaluated using Beck Anxiety Inventory (BAI) and Generalized Anxiety Disorder-7 (GAD-7) assessments. Additionally, the information of participants was recorded in terms of sociodemographic and educational characteristics, antidepressants and anxiolytic use, and consumption of vitamin-mineral supplements. The questionnaires were distributed during the COVID-19 pandemic from December 11, 2020, to January 4, 2021, online via the Microsoft TeamsR platform. It should be mentioned that responses were anonymous. Results: The mean BAI and GAD-7 scores of pharmacy students were 13.1+or-11.2 and 10+or-6.7, respectively. Based on the results, 6% of the students (n=11) revealed potentially concerning levels of anxiety in their BAI responses. Moreover, 31.9% of the pharmacy students (n=59) demonstrated severe anxiety scores on the GAD-7. Positive COVID-19 cases in the family led to statistically significant increases in anxiety on both instruments. Pharmacy students with five years of education (B. Pharm/M. Pharm) showed significantly higher anxiety scores on the BAI. Besides, age correlated negatively with anxiety scores on the GAD-7. Neither antidepressant and anxiolytic use nor vitamin/mineral supplement use were not related to the anxiety scores of participants. Conclusion: Results of this study demonstrated an alarming anxiety status among pharmacy students during the COVID-19 pandemic period. Diagnosis of a family member with COVID-19 was observed to be critical in triggering the anxiety of pharmacy students. Data from this study should raise awareness to take action plans for the mental well-being of pharmacy students during pandemics.

2.
Journal of Advances in Medical and Biomedical Research ; 30(140):211-214, 2022.
Article in English | EMBASE | ID: covidwho-1822723

ABSTRACT

A number of studies have previously provided evidence on the Anti-inflammatory properties of plant-derived compounds that can prevent lung injury. In this study, we attempted to analyze the therapeutic effects of PM 014 on inflammation and pulmonary fibrosis in COVID-19 as well as describing the treatment of one of the most challenging problems related to the coronavirus-19 (COVID-19). We believe that having a close look at all angles of the proposed mechanism goes beyond the physiological consequences of a way to design new strategies for providing an appropriate treatment.

3.
Med Hypotheses ; 143: 109871, 2020 Oct.
Article in English | MEDLINE | ID: covidwho-343478

ABSTRACT

recent studies have provided novel evidence regarding the effect of nicotine agonists on the prevention or modulation of cytokines storm and reduction of infection. In this study we tried to attempt to address these issues from a therapeutic perspective of nicotine agonists in this manner and we describe one of the most challenging theories of immunotherapy in coronavirus-19 (COVID-19). The analysis of the proposed mechanism goes beyond the physiological consequences of a way to design new strategies to provide anti-inflammatory drugs.


Subject(s)
Anti-Inflammatory Agents/administration & dosage , Coronavirus Infections/drug therapy , Coronavirus Infections/immunology , Immune System/drug effects , Immune System/virology , Nicotinic Agonists/administration & dosage , Pneumonia, Viral/drug therapy , Pneumonia, Viral/immunology , Anti-Inflammatory Agents/therapeutic use , Betacoronavirus , Biomarkers/metabolism , COVID-19 , Cholinergic Agents/therapeutic use , Coronavirus Infections/mortality , Cytokines/metabolism , Humans , Immunotherapy , Inflammation , Nicotine/metabolism , Pandemics , Pneumonia, Viral/mortality , Receptors, Nicotinic/metabolism , SARS-CoV-2 , Survivors , Treatment Outcome
SELECTION OF CITATIONS
SEARCH DETAIL